Growth Metrics

TransMedics (TMDX) Cash from Investing Activities (2018 - 2026)

TransMedics has reported Cash from Investing Activities over the past 8 years, most recently at -$15.5 million for Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 14.02% year-over-year to -$15.5 million; the TTM value through Dec 2025 reached -$59.3 million, up 54.18%, while the annual FY2025 figure was -$59.3 million, 54.18% up from the prior year.
  • Cash from Investing Activities for Q4 2025 was -$15.5 million at TransMedics, down from -$7.6 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $24.7 million in Q3 2022 and troughed at -$149.8 million in Q3 2023.
  • A 5-year average of -$14.9 million and a median of -$5.2 million in 2022 define the central range for Cash from Investing Activities.
  • Biggest five-year swings in Cash from Investing Activities: skyrocketed 478.73% in 2022 and later crashed 4665.05% in 2024.
  • Year by year, Cash from Investing Activities stood at $10.0 million in 2021, then crashed by 127.66% to -$2.8 million in 2022, then crashed by 1412.95% to -$41.8 million in 2023, then surged by 67.46% to -$13.6 million in 2024, then fell by 14.02% to -$15.5 million in 2025.
  • Business Quant data shows Cash from Investing Activities for TMDX at -$15.5 million in Q4 2025, -$7.6 million in Q3 2025, and -$9.1 million in Q2 2025.